Sources

8 Total Sources

Insurers Restrict GLP-1 Access as 40% U.S. Obesity Rate Drives Billion-Dollar Cost Fears

Left20%

Center60%

Right20%

ScienceDaily1d ago

GLP-1 Drug Access Restricted by Insurer Costs; Researchers Warn on Compounded Versions

FDA advisers back first four of seven unapproved peptides under review for looser rules | Reuters

Questions to ask a health care provider, insurance and pharmacist before starting a GLP-1

understoodcare.com1d ago

How to Get GLP-1 and Neuropathy Medication Covered on the Same Medicare Plan | Understood Care

The Washington Post12h ago

Medicaid cuts have put Ozempic and other GLP-1 drugs out of reach for some - The Washington Post

FOX 10 News Phoenix1d ago

The hidden cost of GLP-1s: Popularity surge raises long-term affordability questions | FOX 10 Phoenix

Ozempic, Wegovy maker Novo Nordisk slams Hims & Hers Super Bowl ad for compounded GLP-1s | Fortune

WAPT Jackson1d ago

Ole Miss researchers warn cheaper knockoff weight-loss drugs may pose health risks - WAPT